Depression: A Modifiable Risk Factor for Poor Outcomes in Fibromyalgia

BACKGROUND: About 4 out of 10 fibromyalgia patients suffer from depression. The European Alliance of Associations for Rheumatology (EULAR) guidelines recommend using antidepressants to treat fibromyalgia. OBJECTIVE: To determine predictors of improved outcomes following a multicomponent treatment pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Munipalli, Bala, Allman, Madeleine E., Chauhan, Mohit, Niazi, Shehzad K., Rivera, Fernando, Abril, Andy, Wang, Benjamin, Wieczorek, Mikolaj A., Hodge, David O., Knight, Dacre, Perlman, Adam, Abu Dabrh, Abd Moain, Dudenkov, Daniel, Bruce, Barbara K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424873/
https://www.ncbi.nlm.nih.gov/pubmed/36036260
http://dx.doi.org/10.1177/21501319221120738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424873/
https://www.ncbi.nlm.nih.gov/pubmed/36036260
http://dx.doi.org/10.1177/21501319221120738

Ejemplares similares